Reesink-Peters N - Search Results

1

HLA class I alleles and cervical neoplasia.

Visser JT, Hoogeboom BN, Reesink-Peters N, Klip H, Hepkema B, van Velde H, van der Zee AG, Daemen T. Visser JT, et al. J Infect Dis. 2003 May 15;187(10):1675-6. doi: 10.1086/374938. J Infect Dis. 2003. PMID: 12721951 No abstract available.

2

Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG. Wisman GB, et al. Int J Cancer. 2006 Oct 15;119(8):1908-14. doi: 10.1002/ijc.22060. Int J Cancer. 2006. PMID: 16736496 Free article.

3

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.

Reesink-Peters N, Wisman GB, Jéronimo C, Tokumaru CY, Cohen Y, Dong SM, Klip HG, Buikema HJ, Suurmeijer AJ, Hollema H, Boezen HM, Sidransky D, van der Zee AG. Reesink-Peters N, et al. Mol Cancer Res. 2004 May;2(5):289-95. Mol Cancer Res. 2004. PMID: 15192122

4

An overview of innovative techniques to improve cervical cancer screening.

Nijhuis ER, Reesink-Peters N, Wisman GB, Nijman HW, van Zanden J, Volders H, Hollema H, Suurmeijer AJ, Schuuring E, van der Zee AG. Nijhuis ER, et al. Cell Oncol. 2006;28(5-6):233-46. doi: 10.1155/2006/273547. Cell Oncol. 2006. PMID: 17167177 Free PMC article. Review.

5

No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia.

Reesink-Peters N, Ossewaarde JM, Van Der Zee AG, Quint WG, Burger MP, Adriaanse AH. Reesink-Peters N, et al. Sex Transm Infect. 2001 Apr;77(2):101-2. doi: 10.1136/sti.77.2.101. Sex Transm Infect. 2001. PMID: 11287686 Free PMC article.

6

Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.

Reesink-Peters N, Helder MN, Wisman GB, Knol AJ, Koopmans S, Boezen HM, Schuuring E, Hollema H, de Vries EG, de Jong S, van der Zee AG. Reesink-Peters N, et al. J Clin Pathol. 2003 Jan;56(1):31-5. doi: 10.1136/jcp.56.1.31. J Clin Pathol. 2003. PMID: 12499429 Free PMC article.

7

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

Reesink-Peters N, van der Velden J, Ten Hoor KA, Boezen HM, de Vries EG, Schilthuis MS, Mourits MJ, Nijman HW, Aalders JG, Hollema H, Pras E, Duk JM, van der Zee AG. Reesink-Peters N, et al. J Clin Oncol. 2005 Mar 1;23(7):1455-62. doi: 10.1200/JCO.2005.02.123. J Clin Oncol. 2005. PMID: 15735121

8

A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants.

Hougardy BM, Reesink-Peters N, van den Heuvel FA, ten Hoor KA, Hollema H, de Vries EG, de Jong S, van der Zee AG. Hougardy BM, et al. Int J Cancer. 2008 Sep 15;123(6):1457-65. doi: 10.1002/ijc.23684. Int J Cancer. 2008. PMID: 18567003 Free article.

9

Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.

Nijhuis ER, Nijman HW, Oien KA, Bell A, ten Hoor KA, Reesink-Peters N, Boezen HM, Hollema H, van der Zee AG. Nijhuis ER, et al. J Clin Pathol. 2007 Jul;60(7):824-30. doi: 10.1136/jcp.2005.036038. J Clin Pathol. 2007. PMID: 17596548 Free PMC article.

10

Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.

Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, Boezen HM, de Vries EG, de Jong S, van der Zee AG. Reesink-Peters N, et al. Gynecol Oncol. 2005 Mar;96(3):705-13. doi: 10.1016/j.ygyno.2004.10.046. Gynecol Oncol. 2005. PMID: 15721415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page